Vanguard PRIMECAP Fund Ad... (VPMAX)
NASDAQ: VPMAX
· Real-Time Price · USD
183.91
-0.07 (-0.04%)
At close: Mar 31, 2025, 9:30 AM
-0.04% (1D)
Bid | - |
Market Cap | 71.74B |
AUM | 71.7B |
NAV | 183.91 |
EPS (ttm) | 6.63 |
PE Ratio (ttm) | 27.75 |
Shares Out | 390.06M |
Inception Date | Nov 12, 2001 |
Ask | - |
Volume | 0 |
Open | 183.91 |
Previous Close | 183.98 |
Day's Range | 183.91 - 183.91 |
52-Week Range | 142.42 - 185.73 |
Holdings | 171 |
Expense Ratio | 0.29% |
About VPMAX
This large- and mid-capitalization growth fund is managed with a long-term perspective, extremely low turnover, and a well-established investment strategy. Since the fund’s inception in 1984, PRIMECAP Management Company, the advisor, has followed an approach in which multiple portfolio managers independently manage a portion of the fund, which provides diversification of thought. One risk to note is that the fund may become concentrated in a few sectors, notably technology and health care. Short-term performance may be volatile when these sectors are strongly in or out of favor. This fund may be considered a complement to an already diversified portfolio with a long-term time horizon.
Asset Class Large Growth
Ticker Symbol VPMAX
Inception Date Nov 12, 2001
Provider Vanguard
Website Fund Home Page
Exchange NASDAQ
Top Sectors
Sector | Weight % |
---|---|
Technology | 30.38% |
Healthcare | 25.50% |
Industrials | 13.21% |
Consumer Cyclical | 10.84% |
Financial Services | 8.92% |
Top 10 Holdings 33.94% of assets
Name | Symbol | Weight |
---|---|---|
Eli Lilly And Compan... | LLY | 7.59% |
Microsoft Corporatio... | MSFT | 3.71% |
Kla Corporation | KLAC | 3.33% |
Boston Scientific Co... | BSX | 3.32% |
Micron Technology, I... | MU | 3.18% |
Nvidia Corporation | NVDA | 2.87% |
Mktliq | - | 2.57% |
Amgen Inc. | AMGN | 2.47% |
Astrazeneca PLC | AZN | 2.46% |
Alphabet Inc. | GOOGL | 2.44% |